Aileen Patricia Szczepanski et al.
Genome medicine, 12(1), 63-63 (2020-07-17)
Small cell lung cancer (SCLC) is a more aggressive subtype of lung cancer that often results in rapid tumor growth, early metastasis, and acquired therapeutic resistance. Consequently, such phenotypical characteristics of SCLC set limitations on viable procedural options, making it